Altimmune, Inc. (ALT)
2.735
+0.02
(+0.92%)
USD |
NASDAQ |
Jun 08, 16:00
2.73
0.00 (0.00%)
After-Hours: 17:37
Altimmune EPS Diluted (Quarterly) : -0.1813 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | 1.023 |
| Amgen, Inc. | 3.344 |
| Halozyme Therapeutics, Inc. | 1.221 |
| Protalix Biotherapeutics, Inc. | 0.2206 |
| Humacyte, Inc. | -0.089 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -22.56M |
| Total Expenses (Quarterly) | 22.56M |
| Enterprise Value | 57.16M |
| Earnings Yield | -34.28% |
| Normalized Earnings Yield | -34.28 |